NCT04975685

Brief Summary

Background: Multiple Sclerosis (MS) is a chronic condition of the central nervous system; around 1 in 600 people in the United Kingdom have MS. Many people with MS (70%) have cognitive difficulties, which they experience as distressing and disabling, and there is currently a lack of treatment options to improve these difficulties. SMART (Strengthening Mental Abilities with Relational Training) - a theory-based online cognitive training programme, which has been shown to improve general cognitive abilities - has not been tested with people who have MS. Aims: To conduct a feasibility study to inform development of a definitive trial of SMART for improving cognitive functioning in people with MS. The investigators will assess:

  1. 1.Acceptability to participants of the intervention, delivery format, inclusion/exclusion criteria, baseline and outcome measures, randomisation protocol, and study procedures
  2. 2.The framework for a cost-effectiveness analysis alongside a definitive trial
  3. 3.Participant recruitment and retention rates
  4. 4.Sample-size needed for fully powered trial
  5. 5.Signal of efficacy

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2021

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 23, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

February 7, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

December 5, 2023

Status Verified

November 1, 2023

Enrollment Period

2.2 years

First QC Date

July 1, 2021

Last Update Submit

November 28, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Recruitment and retention rates

    Numbers eligible/interested/consented and randomised (and reasons for non-participation), number completing baseline and outcome assessments at Follow-up 1

    16 months

  • Completion rates of outcome measures

    Missing response-data

    6 months

  • Intervention drop-out rate

    Numbers in the intervention condition that drop out (complete \<6 sessions) and reasons for intervention non-completion

    3 months

Other Outcomes (10)

  • Perceived Deficits Questionnaire (PDQ)

    Change between baseline and 3-month follow-up. Additional follow-up at 6 months.

  • Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

    Change between baseline and 3-month follow-up. Additional follow-up at 6 months.

  • Symbol Digit Modalities Test (SDMT)

    Change between baseline and 3-month follow-up. Additional follow-up at 6 months.

  • +7 more other outcomes

Study Arms (3)

TAU + SMART

EXPERIMENTAL

Participants in this arm will receive treatment-as-usual (TAU) plus the experimental SMART intervention (theory-based cognitive training)

Behavioral: SMART

TAU + Sham training

SHAM COMPARATOR

Participants in this arm will receive treatment-as-usual (TAU) plus a control (sham) cognitive training intervention

Behavioral: Sham brain training (Sudoku)

TAU (treatment-as-usual)

NO INTERVENTION

Participants in this arm will receive treatment-as-usual (TAU). Content of TAU for cognitive concerns, based on our clinical experience and knowledge, is often informational support from an MS Nurse with signposting to the MS Society/MS Trust websites.

Interventions

SMARTBEHAVIORAL

SMART (Strengthening Mental Abilities Through Relational Training) is a web-based cognitive training program that directly trains 'relational skills' - skills necessary to understand how concepts relate to one another, which underpin complex cognition.

TAU + SMART

Sudoku was selected to control for expectancy effects based on popular conceptions that it broadly improves cognitive functions, coupled with little evidence supporting this notion, and its use as an active control in similar trials.

TAU + Sham training

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of MS, received ≥3-months pre-enrolment (allowing for acute adjustment, as per other trials of cognitive rehabilitation)
  • Age 18-89 (to meet the standardisation criteria of psychometric assessments)
  • Cognitive difficulties as assessed by Perceived Deficits Questionnaire (PDQ) self-report (≥27) and Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) testing (≤1 standard deviation below normative reference-value)
  • Able to read and speak English to standard necessary for completing assessment and intervention procedures
  • Able and willing to access a computer/tablet/smart-phone with internet connection throughout the study
  • Able and willing to give informed consent

You may not qualify if:

  • Currently receiving cognitive rehabilitation
  • Previously received SMART training
  • Vision or hearing problems precluding completion of procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nottingham Centre for Multiple Sclerosis and Neuroinflammation

Nottingham, United Kingdom

RECRUITING

Related Publications (1)

  • Golijani-Moghaddam N, Dawson DL, Evangelou N, Turton J, Hawton A, Law GR, Roche B, Rowan E, Burge R, Frost AC, das Nair R. Strengthening Mental Abilities with Relational Training (SMART) in multiple sclerosis (MS): study protocol for a feasibility randomised controlled trial. Pilot Feasibility Stud. 2022 Sep 3;8(1):195. doi: 10.1186/s40814-022-01152-7.

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Nima Moghaddam, DClinPsy

    University of Lincoln

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2021

First Posted

July 23, 2021

Study Start

February 7, 2022

Primary Completion

April 30, 2024

Study Completion

April 30, 2024

Last Updated

December 5, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations